Behavioral naltrexone therapy: an integrated treatment for opiate dependance

J. L. ROTHENBERG ; M. A. SULLIVAN ; S. H. CHURCH ; A. SERACINI ; E. COLLINS ; H. D. KLEBER ; E. V. NUNES | 2002
Périodique

ENGLISH : Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating[...]

Plus d'info

Ajouter à la sélection

A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers

E. DAKWAR ; E. V. NUNES ; A. BISAGA ; K. C. CARPENTER ; J. P. MARIANI ; M. A. SULLIVAN ; W. N. RABY ; F. R. LEVIN | 2011
Dans American Journal on Addictions (Vol.20, n°5, September-October 2011) Article : Périodique

Depressive symptoms often coexist with substance use disorders (SUDs). The DSM-IV has identified two distinct categories for depression coexisting with SUDs-independent depression and substance-induced depression. While this distinction has impo[...]

Plus d'info

Ajouter à la sélection

Lien externe

Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence

S. H. CHURCH ; J. L. ROTHENBERG ; M. A. SULLIVAN ; G. BORNSTEIN ; E. V. NUNES | 2001
Périodique

The effect of concurrent nonopiate drug use on outcome of treatment for opiate dependence, Method: Forty-seven opiate-dependent patients received a 6-month course of outpatient treatment with naltrexone and cognitive-behavioral therapy (behavior[...]

Plus d'info

Ajouter à la sélection

Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health

P. ROUX ; C. TINDALL ; L. FUGON ; J. MURRAY ; S. K. VOSBURG ; P. SACCONE ; M. A. SULLIVAN ; J. M. MANUBAY ; Z. D. COOPER ; J. D. JONES ; R. W. FOLTIN ; S. D. COMER | 2012
Dans Addiction (Vol.107, n°3, March 2012) Article : Périodique

Aims: Research on drug dependence often involves the administration of drugs of abuse to experienced drug users under controlled laboratory conditions. The primary objective of this study was to assess whether participation in such research alte[...]

Plus d'info

Ajouter à la sélection

Lien externe

Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants

G. K. HULSE ; R. J. TAIT ; S. D. COMER ; M. A. SULLIVAN ; I. G. JACOBS ; D. ARNOLD-REED | 2005
Périodique

ENGLISH : Background: Non-fatal overdoses represent a significant morbidity for regular heroin users. Naltrexone is an opioid antagonist capable of blocking the effects of heroin, thereby preventing accidental overdose. However, treatment with[...]

Plus d'info

Ajouter à la sélection